Since the discovery of human iPS cells, a principal goal for researchers worldwide has been to use them for various medical applications, including cell therapy. Among different human diseases, type 1 diabetes mellitus (T1DM) has been a top priority for cell therapy development.
This article was originally published on MedicalXpress.com